Seeing Is Believing
Currently out of the existing stock ratings of Jeffrey Garro, 56 are a BUY (67.47%), 25 are a HOLD (30.12%), 2 are a SELL (2.41%).
Analyst Jeffrey Garro, currently employed at STEPHENS, carries an average stock price target met ratio of 41.56% that have a potential upside of 13.16% achieved within 91 days.
Jeffrey Garro’s has documented 165 price targets and ratings displayed on 15 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on MDRX, Allscripts Healthcare Solutions at 14-Nov-2023.
Analyst best performing recommendations are on TDOC (TELADOC).
The best stock recommendation documented was for TDOC (TELADOC) at 7/26/2023. The price target of $28 was fulfilled within 1 day with a profit of $0.92 (3.18%) receiving and performance score of 31.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
37.5
35
2 years 7 months 27 days ago
2/2 (100%)
$0.21 (0.56%)
84
Hold
37.5
40
2 years 7 months 28 days ago
2/3 (66.67%)
$0.02 (0.05%)
42
Buy
40
$2.5 (6.67%)
41
2 years 8 months ago
2/4 (50%)
$10.28 (34.59%)
19
Buy
39
$1.5 (4.00%)
43
2 years 9 months 19 days ago
6/8 (75%)
$9.25 (31.09%)
21
Buy
40
$2.5 (6.67%)
35
2 years 9 months 22 days ago
4/5 (80%)
$9.49 (31.10%)
18
What Year was the first public recommendation made by Jeffrey Garro?